# FDA Investigational Device Exemption **Type:** Regulatory pathway **Collection:** [[collections/Neurotech|Neurotech]] **Primary source:** [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] ## Definition An Investigational Device Exemption is the FDA pathway named in connection with Paradromics' 2025 clinical authorization. ## Relationships [[wiki/FDA Investigational Device Exemption|Investigational Device Exemption]] is related to [[wiki/Paradromics|Paradromics]] and [[wiki/Connexus Direct Data Interface|Connexus Direct Data Interface]] through clinical investigation authorization. ## Source route [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[collections/Neurotech|Neurotech]]